Cite

HARVARD Citation

    Suliman, M. et al. (2019). Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non‐surgical and bariatric surgery patients. Diabetes, obesity & metabolism. 21 (6), pp. 1498-1501. [Online]. 
  
Back to record